ARTICLE SUMMARY:
RND redux: read our three-part series on the renal denervation market, including interviews with execs at the center of the revival, Medtronic’s Jason Weidman and ReCor Medical’s Andrew Weiss. Also in this issue, an update on cerebral embolic protection devices, electrosurgical innovations from Creo Medical, PAVmed’s fast-to-market medtech model, selling into APAC markets, and boosting clinical uptake of digital pathology tools.
